{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:12:02Z","timestamp":1791267122850,"version":"4.1.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biopha.2025.118833","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:34:21Z","timestamp":1767681261000},"page":"118833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Beyond IOP: Neuroprotection and neuroregeneration as important therapeutic strategies for glaucoma"],"prefix":"10.1016","volume":"194","author":[{"given":"Shivani","family":"Makhijani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Khobragade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib1","first-page":"6509809","article-title":"Medical management of glaucoma in the 21st century from a Canadian perspective","volume":"2016","author":"Harasymowycz","year":"2016","journal-title":"J. Ophthalmol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118833_bib2","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.biopha.2025.118833_bib3","doi-asserted-by":"crossref","unstructured":"Allison K., Patel D., Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020 Nov 24;12(11).","DOI":"10.7759\/cureus.11686"},{"issue":"13","key":"10.1016\/j.biopha.2025.118833_bib4","first-page":"225","article-title":"The diagnosis and treatment of glaucoma","volume":"117","author":"Schuster","year":"2020","journal-title":"Dtsch. \u00c4rzteblatt Int."},{"key":"10.1016\/j.biopha.2025.118833_bib5","article-title":"Nanomedicine in glaucoma treatment; current challenges and future perspectives","volume":"28","author":"Iqbal","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"3","key":"10.1016\/j.biopha.2025.118833_bib6","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4103\/IJO.IJO_379_23","article-title":"Toward better management of glaucoma in India","volume":"71","author":"Rewri","year":"2023","journal-title":"Indian J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118833_bib7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.exer.2010.08.009","article-title":"Neuroprotection in glaucoma\u2013is there a future role?","volume":"91","author":"Baltmr","year":"2010","journal-title":"Exp. eye Res."},{"key":"10.1016\/j.biopha.2025.118833_bib8","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/S0039-6257(99)00029-6","article-title":"Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death","volume":"43","author":"Nickells","year":"1999","journal-title":"Surv. Ophthalmol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118833_bib9","first-page":"379","article-title":"Cell-death during development of the nervous-system","volume":"17","author":"Homma","year":"1995","journal-title":"Jpn. J. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118833_bib10","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/nrn1434","article-title":"Oxidative stress in neurodegeneration: cause or consequence?","volume":"10","author":"Andersen","year":"2004","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/2008-322X.183923","article-title":"Neuroprotection in glaucoma","volume":"11","author":"Doozandeh","year":"2016","journal-title":"J. Ophthalmic Vis. Res."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118833_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.2017.0041","article-title":"Targets of neuroprotection in glaucoma","volume":"34","author":"He","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib13","first-page":"6138132","article-title":"Current medical therapy and future trends in the management of glaucoma treatment","volume":"2020","author":"Cvenkel","year":"2020","journal-title":"J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib14","first-page":"6138132","article-title":"Current medical therapy and future trends in the management of glaucoma treatment","volume":"2020","author":"Cvenkel","year":"2020","journal-title":"J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118833_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1442-9071.2011.02563.x","article-title":"Translational neuroprotection research in glaucoma: a review of definitions and principles","volume":"40","author":"Casson","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118833_bib16","first-page":"2109","article-title":"Current perspective of neuroprotection and glaucoma","author":"Tian","year":"2015","journal-title":"Clin. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118833_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures","volume":"126","author":"Group","year":"1998","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118833_bib18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ophtha.2007.04.062","article-title":"Prevalence of primary open-angle glaucoma in an urban south Indian population and comparison with a rural population: the Chennai Glaucoma Study","volume":"115","author":"Vijaya","year":"2008","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.14336\/AD.2023.0630-1","article-title":"Aging, cellular senescence, and glaucoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Aging Dis."},{"issue":"5","key":"10.1016\/j.biopha.2025.118833_bib20","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1167\/iovs.06-0573","article-title":"Elevated hydrostatic pressure triggers mitochondrial fission and decreases cellular ATP in differentiated RGC-5 cells","volume":"48","author":"Ju","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/glia.10051","article-title":"Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray","volume":"38","author":"Hernandez","year":"2002","journal-title":"Glia"},{"issue":"11","key":"10.1016\/j.biopha.2025.118833_bib22","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1167\/iovs.07-1447","article-title":"Longitudinal profile of retinal ganglion cell damage after optic nerve crush with blue-light confocal scanning laser ophthalmoscopy","volume":"49","author":"Leung","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2025.118833_bib23","first-page":"2554","article-title":"Microarray analysis of gene expression in the aging human retina","volume":"43","author":"Yoshida","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/antiox10020238","article-title":"Oxidative stress and the role of NADPH oxidase in glaucoma","volume":"10","author":"Fan Gaskin","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2025.118833_bib25","first-page":"2488","article-title":"Role of miR-29b on the regulation of the extracellular matrix in human trabecular meshwork cells under chronic oxidative stress","volume":"15","author":"Luna","year":"2009","journal-title":"Mol. Vis."},{"issue":"5","key":"10.1016\/j.biopha.2025.118833_bib26","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3390\/antiox11050886","article-title":"The intertwined roles of oxidative stress and endoplasmic reticulum stress in glaucoma","volume":"11","author":"Hurley","year":"2022","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.biopha.2025.118833_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.exer.2008.07.011","article-title":"Oxidative injury to blood vessels and glia of the prelaminar optic nerve head in human glaucoma","volume":"87","author":"Feilchenfeld","year":"2008","journal-title":"Exp. eye Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib28","first-page":"38","article-title":"Ocular blood flow and influencing factors for glaucoma","volume":"5","author":"Nakazawa","year":"2016","journal-title":"AsiaPac. J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118833_bib29","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3390\/antiox10121948","article-title":"Role of oxidative stress in ocular diseases associated with retinal ganglion cells degeneration","volume":"10","author":"Kang","year":"2021","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-8993(02)03731-9","article-title":"Neuroprotection by memantine against neurodegeneration induced by \u03b2-amyloid (1\u201340)","volume":"958","author":"Miguel-Hidalgo","year":"2002","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.biopha.2025.118833_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF02153655","article-title":"Histologic changes in the inner retina of albino rats following intravitreal injection of monosodiuml-glutamate","volume":"223","author":"Sisk","year":"1985","journal-title":"Graefe's. Arch. Clin. Exp. Ophthalmol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118833_bib32","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/bjo.83.8.980","article-title":"Ganglion cell death in glaucoma: what do we truly know?","volume":"83","author":"Osborne","year":"1999","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118833_bib33","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1016\/S0039-6257(01)00198-9","article-title":"New horizons in neuroprotection","volume":"45","author":"Naskar","year":"2001","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2202-11-31","article-title":"Neuroprotective effects of bis (7)-tacrine against glutamate-induced retinal ganglion cells damage","volume":"11","author":"Fang","year":"2010","journal-title":"BMC Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118833_bib35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.18240\/ijo.2023.05.20","article-title":"Mitochondrial dysfunction in glaucomatous degeneration","volume":"16","author":"Zhang","year":"2023","journal-title":"Int. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.02-0333","article-title":"Varicosities of intraretinal ganglion cell axons in human and nonhuman primates","volume":"44","author":"Wang","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"25","key":"10.1016\/j.biopha.2025.118833_bib37","doi-asserted-by":"crossref","first-page":"10190","DOI":"10.1073\/pnas.1107402108","article-title":"Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation","volume":"108","author":"Rambold","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118833_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mito.2017.02.002","article-title":"Mitochondrial function in M\u00fcller cells-Does it matter?","volume":"36","author":"Toft-Kehler","year":"2017","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biopha.2025.118833_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fnagi.2014.00311","article-title":"Bioenergetic dysfunction and inflammation in Alzheimer\u2019s disease: a possible connection","volume":"6","author":"Wilkins","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib40","first-page":"4581909","article-title":"Neuroinflammatory mechanisms of mitochondrial dysfunction and neurodegeneration in glaucoma","volume":"2021","author":"Duarte","year":"2021","journal-title":"J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118833_bib41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2025.118833_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.699623","article-title":"Crosstalk between dysfunctional mitochondria and inflammation in glaucomatous neurodegeneration","volume":"12","author":"Jassim","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118833_bib43","first-page":"40","article-title":"In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis)","volume":"110","author":"Baudouin","year":"2012","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.biopha.2025.118833_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100916","article-title":"Inflammation in Glaucoma: from the back to the front of the eye, and beyond","volume":"83","author":"Baudouin","year":"2021","journal-title":"Prog. Retin. eye Res."},{"issue":"10","key":"10.1016\/j.biopha.2025.118833_bib45","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1167\/iovs.07-1575","article-title":"Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma","volume":"49","author":"Shibuya","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2025.118833_bib46","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1167\/iovs.10-5407","article-title":"Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling","volume":"51","author":"Luo","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118833_bib47","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3109\/02713683.2014.997884","article-title":"Evaluation of genetic polymorphisms in clusterin and tumor necrosis factor-alpha genes in South Indian individuals with pseudoexfoliation syndrome","volume":"40","author":"Dubey","year":"2015","journal-title":"Curr. eye Res."},{"key":"10.1016\/j.biopha.2025.118833_bib48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/bs.pmbts.2015.04.008","article-title":"Glaucoma genes and mechanisms","volume":"134","author":"Wiggs","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.biopha.2025.118833_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neulet.2013.10.012","article-title":"Astrocyte loss and astrogliosis in neuroinflammatory disorders","volume":"565","author":"Hostenbach","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"35","key":"10.1016\/j.biopha.2025.118833_bib50","doi-asserted-by":"crossref","first-page":"12088","DOI":"10.1523\/JNEUROSCI.1273-15.2015","article-title":"Soluble tumor necrosis factor alpha promotes retinal ganglion cell death in glaucoma via calcium-permeable AMPA receptor activation","volume":"35","author":"Vargas","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118833_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.exer.2017.02.014","article-title":"Neuroinflammation in glaucoma: a new opportunity","volume":"157","author":"Williams","year":"2017","journal-title":"Exp. eye Res."},{"issue":"9774","key":"10.1016\/j.biopha.2025.118833_bib52","volume":"377","author":"Quigley","year":"2011","journal-title":"Glaucoma Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2025.118833_bib53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/IJG.0b013e31815c3a7f","article-title":"Oxidative stress in primary open-angle glaucoma","volume":"17","author":"Zanon-Moreno","year":"2008","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.biopha.2025.118833_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.699623","article-title":"Crosstalk between dysfunctional mitochondria and inflammation in glaucomatous neurodegeneration","volume":"12","author":"Jassim","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118833_bib55","first-page":"1940","article-title":"Concurrent downregulation of a glutamate transporter and receptor in glaucoma","volume":"41","author":"Naskar","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118833_bib56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma","volume":"21","author":"Flammer","year":"2002","journal-title":"Prog. Retin. eye Res."},{"key":"10.1016\/j.biopha.2025.118833_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","article-title":"Glia\u2013neuron interactions in the mammalian retina","volume":"51","author":"Vecino","year":"2016","journal-title":"Prog. Retin. eye Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118833_bib58","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cne.22516","article-title":"Early microglia activation in a mouse model of chronic glaucoma","volume":"519","author":"Bosco","year":"2011","journal-title":"J. Comp. Neurol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118833_bib59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jamaophthalmol.2019.0005","article-title":"Myocilin mutations in patients with normal-tension glaucoma","volume":"137","author":"Alward","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118833_bib60","doi-asserted-by":"crossref","first-page":"S284","DOI":"10.1016\/S0039-6257(01)00200-4","article-title":"Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey","volume":"45","author":"Hare","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118833_bib61","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0079-6123(08)01134-5","article-title":"Targeting excitotoxic\/free radical signaling pathways for therapeutic intervention in glaucoma","volume":"173","author":"Seki","year":"2008","journal-title":"Prog. brain Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118833_bib62","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1167\/iovs.07-1363","article-title":"Expression of nitrotyrosine and oxidative consequences in the trabecular meshwork of patients with primary open-angle glaucoma","volume":"49","author":"Fern\u00e1ndez-Durango","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118833_bib63","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.ophtha.2018.06.017","article-title":"Oral memantine for the treatment of glaucoma: design and results of 2 randomized, placebo-controlled, phase 3 studies","volume":"125","author":"Weinreb","year":"2018","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.biopha.2025.118833_bib64","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/02713683.2011.556299","article-title":"Evaluation of oxidative stress markers in aqueous humor of primary open angle glaucoma and primary angle closure glaucoma patients","volume":"39","author":"Goyal","year":"2014","journal-title":"Curr. eye Res."},{"issue":"8","key":"10.1016\/j.biopha.2025.118833_bib65","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/ph16081146","article-title":"Oxidative stress and antioxidant-based interventional medicine in ophthalmology","volume":"16","author":"Honisch","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.biopha.2025.118833_bib66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1179\/135100099101534882","article-title":"Nicotinamide (vitamin B3) as an effective antioxidant against oxidative damage in rat brain mitochondria","volume":"4","author":"Kamat","year":"1999","journal-title":"Redox Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118833_bib67","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/nu10040387","article-title":"Dietary niacin and open-angle glaucoma: the Korean national health and nutrition examination survey","volume":"10","author":"Jung","year":"2018","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.biopha.2025.118833_bib68","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/ph16091193","article-title":"Immunomodulatory and antioxidant drugs in glaucoma treatment","volume":"16","author":"Buonfiglio","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.biopha.2025.118833_bib69","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3390\/antiox9111031","article-title":"Glaucoma and antioxidants: review and update","volume":"9","author":"Garcia-Medina","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2025.118833_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101988","article-title":"Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction","volume":"43","author":"Tribble","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118833_bib71","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0079-6123(08)01139-4","article-title":"Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection","volume":"173","author":"Russo","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib72","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coph.2012.09.008","article-title":"Oxidative stress and mitochondrial dysfunction in glaucoma","volume":"13","author":"Chrysostomou","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057828","article-title":"Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model","volume":"8","author":"Begum","year":"2013","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.biopha.2025.118833_bib74","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1751-1097.2012.01120.x","article-title":"Light might directly affect retinal ganglion cell mitochondria to potentially influence function","volume":"88","author":"del Olmo-Aguado","year":"2012","journal-title":"Photochem. Photobiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/clm.2000.18.67","article-title":"Wound healing of animal and human body sport and traffic accident injuries using low-level laser therapy treatment: a randomized clinical study of seventy-four patients with control group","volume":"18","author":"Simunovic","year":"2000","journal-title":"J. Clin. Laser Med. Surg."},{"issue":"6","key":"10.1016\/j.biopha.2025.118833_bib76","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1073\/pnas.0534746100","article-title":"Therapeutic photobiomodulation for methanol-induced retinal toxicity","volume":"100","author":"Eells","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118833_bib77","first-page":"2566","article-title":"Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension","volume":"41","author":"Orzalesi","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2025.118833_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.566858","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative motor neuron disease with ocular involvement","volume":"14","author":"Rojas","year":"2020","journal-title":"Front. Neurosci."},{"issue":"45","key":"10.1016\/j.biopha.2025.118833_bib79","doi-asserted-by":"crossref","first-page":"72503","DOI":"10.18632\/oncotarget.12700","article-title":"Wogonin prevents TLR4-NF-\u03baB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00210-017-1433-9","article-title":"Baicalin alleviates oxidative stress damage in trabecular meshwork cells in vitro","volume":"391","author":"Gong","year":"2018","journal-title":"NaunynSchmiede 's. Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib81","first-page":"9","article-title":"Clinical and epidemiological study in patients with primary open-angle glaucoma. Revista Brasileira de","volume":"77","author":"Ribeiro","year":"2018","journal-title":"Oftalmologia"},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib82","first-page":"7108948","article-title":"Progress in gene therapy to prevent retinal ganglion cell loss in glaucoma and Leber\u2019s hereditary optic neuropathy","volume":"2018","author":"Ratican","year":"2018","journal-title":"Neural Plast."},{"key":"10.1016\/j.biopha.2025.118833_bib83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2016.03.003","article-title":"Pharmacology of novel intraocular pressure-lowering targets that enhance conventional outflow facility: pitfalls, promises and what lies ahead?","volume":"787","author":"Prasanna","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118833_bib84","first-page":"32","article-title":"Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures","volume":"8","author":"Vittitow","year":"2002","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.biopha.2025.118833_bib85","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ymthe.2019.12.012","article-title":"Gene therapy for glaucoma by ciliary body aquaporin 1 disruption using CRISPR-Cas9","volume":"28","author":"Wu","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2025.118833_bib86","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2017.11.019","article-title":"Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)","volume":"186","author":"Serle","year":"2018","journal-title":"Am. J. Ophthalmol."},{"issue":"13","key":"10.1016\/j.biopha.2025.118833_bib87","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.65.13.43","article-title":"The mechanisms of neuroprotection by topical rho kinase inhibition in experimental mouse glaucoma and optic neuropathy","volume":"65","author":"Quillen","year":"2024","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib88","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/eop.11.3","article-title":"Stem cell therapy for glaucoma: possibilities and practicalities","volume":"6","author":"Johnson","year":"2011","journal-title":"Expert Rev. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib89","first-page":"9415367","article-title":"Bioprocessing of mesenchymal stem cells and their derivatives: toward cell-free therapeutics","volume":"2018","author":"Phelps","year":"2018","journal-title":"Stem Cells Int."},{"issue":"20","key":"10.1016\/j.biopha.2025.118833_bib90","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.3390\/ijms222011077","article-title":"The future of stem cells and their derivates in the treatment of glaucoma. A critical point of view","volume":"22","author":"Nicoar\u0103","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib91","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12864-017-3758-7","article-title":"Transcriptome analysis for the identification of cellular markers related to trabecular meshwork differentiation","volume":"18","author":"Sathiyanathan","year":"2017","journal-title":"BMC Genom."},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib92","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1167\/iovs.12-11056","article-title":"Stem cells from trabecular meshwork home to TM tissue in vivo","volume":"54","author":"Du","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2025.118833_bib93","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1167\/iovs.14-14800","article-title":"Induction of trabecular meshwork cells from induced pluripotent stem cells","volume":"55","author":"Ding","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118833_bib94","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.15-18590","article-title":"The potential of human stem cells for the study and treatment of glaucoma","volume":"57","author":"Chamling","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118833_bib95","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1167\/iovs.09-4509","article-title":"Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma","volume":"51","author":"Johnson","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13287-020-02130-7","article-title":"Human mesenchymal stem cell therapy promotes retinal ganglion cell survival and target reconnection after optic nerve crush in adult rats","volume":"12","author":"da Silva-Junior","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2025.118833_bib97","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.12.7.23","article-title":"Cell-based therapies for glaucoma","volume":"12","author":"Luis","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118833_bib98","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/pharmaceutics15030837","article-title":"Nanocarriers for the delivery of neuroprotective agents in the treatment of ocular neurodegenerative diseases","volume":"15","author":"Patel","year":"2023","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.biopha.2025.118833_bib99","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJMoa1609583","article-title":"Vision loss after intravitreal injection of autologous \u201cstem cells\u201d for AMD","volume":"376","author":"Kuriyan","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2025.118833_bib100","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3928\/23258160-20160601-16","article-title":"Retinal detachment after subretinal stem cell transplantation","volume":"47","author":"Leung","year":"2016","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"key":"10.1016\/j.biopha.2025.118833_bib101","unstructured":"Turbert D. Stem Cell Therapy for Eye Disease: What You Need to Know."},{"issue":"6","key":"10.1016\/j.biopha.2025.118833_bib102","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/mi11060612","article-title":"Tissue-engineered models for glaucoma research","volume":"11","author":"Lu","year":"2020","journal-title":"Micromachines"},{"issue":"12","key":"10.1016\/j.biopha.2025.118833_bib103","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1001\/archopht.123.12.1725","article-title":"Tissue bioengineering: potential applications to glaucoma","volume":"123","author":"Young","year":"2005","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib104","doi-asserted-by":"crossref","first-page":"1701808","DOI":"10.1002\/smll.201701808","article-title":"Memantine-loaded PEGylated biodegradable nanoparticles for the treatment of glaucoma","volume":"14","author":"S\u00e1nchez-L\u00f3pez","year":"2018","journal-title":"Small"},{"issue":"8","key":"10.1016\/j.biopha.2025.118833_bib105","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.nano.2014.05.010","article-title":"Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: toward noninvasive glaucoma gene therapy","volume":"10","author":"Alqawlaq","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2025.118833_bib106","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3390\/ijms22052360","article-title":"Role of retinal amyloid-\u03b2 in neurodegenerative diseases: overlapping mechanisms and emerging clinical applications","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118833_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-01199-3","article-title":"Polydopamine NPs attenuate retina ganglion cell degeneration and restore visual function after optic nerve injury","volume":"19","author":"Lou","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118833_bib108","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3390\/polym15061373","article-title":"Breaking barriers in eye treatment: polymeric nanobased drug-delivery system for anterior segment diseases and glaucoma","volume":"15","author":"Wu","year":"2023","journal-title":"Polymers"},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118833_bib109","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijpharm.2013.11.043","article-title":"Acetazolamide encapsulated dendritic nanoarchitectures for effective glaucoma management in rabbits","volume":"461","author":"Mishra","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118833_bib110","first-page":"733","article-title":"Photoreceptor preservation induced by intravitreal controlled delivery of GDNF and GDNF\/melatonin in rhodopsin knockout mice","volume":"24","author":"Garc\u00eda-Caballero","year":"2018","journal-title":"Mol. Vis."},{"issue":"24","key":"10.1016\/j.biopha.2025.118833_bib111","doi-asserted-by":"crossref","first-page":"9015","DOI":"10.3390\/app10249015","article-title":"Neurotrophic factors in glaucoma and innovative delivery systems","volume":"10","author":"Mallone","year":"2020","journal-title":"Appl. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118833_bib112","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.3390\/nu12103158","article-title":"Natural products: evidence for neuroprotection to be exploited in glaucoma","volume":"12","author":"Adornetto","year":"2020","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.biopha.2025.118833_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291836","article-title":"Efficacy of citicoline as a supplement in glaucoma patients: A systematic review","volume":"18","author":"Prinz","year":"2023","journal-title":"Plos One"},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib114","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/1673-5374.244781","article-title":"Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma","volume":"14","author":"Martucci","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118833_bib115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/nu14030534","article-title":"Treatment of glaucoma with natural products and their mechanism of action: an update","volume":"14","author":"Sim","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.biopha.2025.118833_bib116","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1166\/jbn.2014.1897","article-title":"Resveratrol-loaded nanoparticles reduce oxidative stress induced by radiation or amyloid-in transgenic Caenorhabditis elegans","volume":"10","author":"Yin","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biopha.2025.118833_bib117","series-title":"InHandbook of Nutrition, Diet, and the Eye","first-page":"189","author":"Miyamoto","year":"2019"},{"key":"10.1016\/j.biopha.2025.118833_bib118","first-page":"390","article-title":"Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma","volume":"18","author":"ybulska-Heinrich","year":"2012","journal-title":"Mol. Vis."},{"issue":"6","key":"10.1016\/j.biopha.2025.118833_bib119","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.exer.2006.10.018","article-title":"Melatonin in the eye: implications for glaucoma","volume":"84","author":"Lundmark","year":"2007","journal-title":"Exp. eye Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41419-019-1365-z","article-title":"Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma","volume":"10","author":"Sano","year":"2019","journal-title":"Cell death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib121","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s11671-024-04154-x","article-title":"Advances in dorzolamide hydrochloride delivery: harnessing nanotechnology for enhanced ocular drug delivery in glaucoma management","volume":"19","author":"Pardeshi","year":"2024","journal-title":"Discov. Nano"},{"key":"10.1016\/j.biopha.2025.118833_bib122","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.exer.2015.04.013","article-title":"Neuroprotective effect of memantine on the retinal ganglion cells of APPswe\/PS1\u0394E9 mice and its immunomodulatory mechanisms","volume":"135","author":"Gao","year":"2015","journal-title":"Exp. Eye Res."},{"issue":"11","key":"10.1016\/j.biopha.2025.118833_bib123","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.4314\/tjpr.v17i11.9","article-title":"Curcumin protects trabecular meshwork cells against hydrogen peroxide-induced oxidative stress and apoptosis via Nrf2-keap1 pathway","volume":"17","author":"Luo","year":"2018","journal-title":"Trop. J. Pharm. Res."},{"issue":"09","key":"10.1016\/j.biopha.2025.118833_bib124","article-title":"Role of polyphenolic compounds in management of oxidative stress associated with glaucoma","volume":"7","author":"Chakole","year":"2020","journal-title":"Eur. J. Mol. Clin. Med."},{"issue":"6","key":"10.1016\/j.biopha.2025.118833_bib125","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0028-3908(02)00129-6","article-title":"\u03b1-Lipoic acid protects the retina against ischemia-reperfusion","volume":"43","author":"Chidlow","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118833_bib126","doi-asserted-by":"crossref","first-page":"1521188","DOI":"10.3389\/fphar.2024.1521188","article-title":"Protective effect of resveratrol on retinal damage in glaucoma: a systematic review and meta-analysis of preclinical studies","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118833_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065389","article-title":"\u03b1-Lipoic acid antioxidant treatment limits glaucoma-related RGC death and dysfunction","volume":"8","author":"Inman","year":"2013","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib128","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1196\/annals.1352.023","article-title":"Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761","volume":"1056","author":"Eckert","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib129","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0161-6420(02)01745-1","article-title":"Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma","volume":"110","author":"Quaranta","year":"2003","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1167\/iovs.13-13168","article-title":"Effect of Ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: a randomized, crossover clinical trial","volume":"55","author":"Guo","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4a","key":"10.1016\/j.biopha.2025.118833_bib131","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S1368980000000574","article-title":"Efficacy and safety of a Ginkgo biloba extract","volume":"3","author":"Le Bars","year":"2000","journal-title":"Public Health Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib132","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/nu11020239","article-title":"Substances of interest that support glaucoma therapy","volume":"11","author":"Sacc\u00e0","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118833_bib133","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40263-014-0144-8","article-title":"Neuroprotective properties of citicoline: facts, doubts and unresolved issues","volume":"28","author":"Grieb","year":"2014","journal-title":"CNS Drugs"},{"issue":"16","key":"10.1016\/j.biopha.2025.118833_bib134","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/00001756-200211150-00023","article-title":"Citicoline has a protective effect on damaged RGCs in mouse culture retina","volume":"13","author":"Oshitari","year":"2002","journal-title":"Neuroreport"},{"issue":"8","key":"10.1016\/j.biopha.2025.118833_bib135","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3390\/jcm13082214","article-title":"Optic nerve neuroprotection in glaucoma: a narrative review","volume":"13","author":"D\u2019Angelo","year":"2024","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.biopha.2025.118833_bib136","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/jpm12111884","article-title":"Neuroprotection in glaucoma: basic aspects and clinical relevance","volume":"12","author":"Kuo","year":"2022","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib137","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9394(14)73755-9","article-title":"Initial clinical experience with the Ahmed glaucoma valve implant","volume":"120","author":"Coleman","year":"1995","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118833_bib138","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2147\/OPTH.S342721","article-title":"Ahmed glaucoma valve implantation to reduce IOP: updated perspectives. Clinical","author":"Arikan","year":"2023","journal-title":"Clinic. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118833_bib139","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9394(14)73756-0","article-title":"Early clinical experience with the Baerveldt implant in complicated glaucomas","volume":"120","author":"Hodkin","year":"1995","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118833_bib140","first-page":"2789","article-title":"The baerveldt glaucoma drainage device: efficacy, safety, and place in therapy. Clinical","author":"Poelman","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2025.118833_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-015-0115-y","article-title":"Comparison of the ahmed glaucoma valve with the baerveldt glaucoma implant: a meta-analysis","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Ophthalmol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118833_bib142","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0420.2005.00450.x","article-title":"Placing the Molteno implant in a long scleral tunnel to prevent postoperative tube exposure","volume":"83","author":"Ollila","year":"2005","journal-title":"Acta Ophthalmol. Scand."},{"issue":"9","key":"10.1016\/j.biopha.2025.118833_bib143","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bjo.53.9.606","article-title":"New implant for drainage in glaucoma. Clinical trial","volume":"53","author":"Molteno","year":"1969","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118833_bib144","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00441-013-1584-z","article-title":"Challenges in the development of glaucoma neuroprotection therapy","volume":"353","author":"Liu","year":"2013","journal-title":"Cell Tissue Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118833_bib145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/01658107.2013.830627","article-title":"Screening for patients with mild Alzheimer Disease using frequency doubling technology perimetry","volume":"37","author":"Aykan","year":"2013","journal-title":"NeuroOphthalmology"},{"issue":"3","key":"10.1016\/j.biopha.2025.118833_bib146","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5005\/jp-journals-10078-1415","article-title":"A retrospective cohort study on the difficulties of diagnosing and managing glaucoma in patients with coexistent neurodegenerative disease","volume":"17","author":"Ciociola","year":"2023","journal-title":"J. Curr. Glaucoma Pract."},{"issue":"5","key":"10.1016\/j.biopha.2025.118833_bib147","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s41433-018-0050-2","article-title":"Neuroprotective agents in the management of glaucoma","volume":"32","author":"Nucci","year":"2018","journal-title":"Eye"},{"issue":"10","key":"10.1016\/j.biopha.2025.118833_bib148","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/jpm14101062","article-title":"Artificial intelligence and advanced technology in glaucoma: a review","volume":"14","author":"Tonti","year":"2024","journal-title":"J. Pers. Med."},{"issue":"2","key":"10.1016\/j.biopha.2025.118833_bib149","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/ICU.0000000000000552","article-title":"Artificial intelligence in glaucoma","volume":"30","author":"Zheng","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118833_bib150","doi-asserted-by":"crossref","first-page":"1173094","DOI":"10.3389\/fcell.2023.1173094","article-title":"The application of artificial intelligence in glaucoma diagnosis and prediction","volume":"11","author":"Zhang","year":"2023","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:27:47Z","timestamp":1769034467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225010273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":150,"alternative-id":["S0753332225010273"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118833","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond IOP: Neuroprotection and neuroregeneration as important therapeutic strategies for glaucoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118833"}}